Morgan Stanley
TCBP

Morgan Stanley’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Morgan Stanley’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$473 – 8245
2024
Q3 		$473 Buy
+6
New +$611 ﹤0.01% 7305
2023
Q2 		– Hold
0
– -$32 – 7731
2023
Q1 		– Hold
0
– – – 7625

Other funds holding TCBP

CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
NECFA
New England Capital Financial Advisors Meriden, Connecticut $365M AUM 17.32% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return

Morgan Stanley's TCBP Position: Q4 2024 in Review

Morgan Stanley sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q4 2024, closing a stake of 6 shares — an estimated $473 sold.

Morgan Stanley first reported a position in TCBP in Q3 2024 and held it in 1 quarter. The position peaked at $473 in Q3 2024. 12 funds tracked by Wall St. Rank hold TCBP as of Q4 2024.

  • Morgan Stanley reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 6 TC BioPharm (Holdings) plc American Depositary Shares shares in Q4 2024, an estimated $473.
  • Morgan Stanley first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q3 2024 and held it in 1 quarter.
  • Morgan Stanley's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $473 in Q3 2024.
  • 12 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.